Solutions: Building a Link Between Toxicology and Microarray Data at the FDA | GenomeWeb

Weida Tong, who got his PhD from Fudan University in China, moved to Little Rock, Ark., in 1996 to work for the US Food and Drug Administration’s National Center for Toxicological Research, developing a database of endocrine disruptors.

Seven years later, Tong is still at the NCTR, and in June 2002 was named the director of the new Center for Toxicoinformatics, where his first task has been to develop a way to handle the center’s growing body of toxicology-related microarray data.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.